Journal Article

Randomised phase III trial of docetaxel/carboplatin vs MIC/MVP chemotherapy in advanced non-small cell lung cancer (NSCLC) - final results of a British Thoracic Oncology Group (BTOG) trial

  • Lorigan P
  • Booton R
  • Ashcroft L
  • et al.
Journal of Clinical Oncology (2004) 22(14_suppl) 7066-7066
DOI: 10.1200/jco.2004.22.90140.7066
N/ACitations
Citations of this article
1Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Abstracts for the 40th Annual Meeting of the American Society of Clinical Oncology, New Orleans,LA, 5‐8 June, 2004 [Abstract No. 7066]

Cite

CITATION STYLE

APA

Lorigan, P., Booton, R., Ashcroft, L., O’Byrne, K., Anderson, H., Nicolson, M., … Thatcher, N. (2004). Randomised phase III trial of docetaxel/carboplatin vs MIC/MVP chemotherapy in advanced non-small cell lung cancer (NSCLC) - final results of a British Thoracic Oncology Group (BTOG) trial. Journal of Clinical Oncology, 22(14_suppl), 7066–7066. https://doi.org/10.1200/jco.2004.22.90140.7066

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free